|
End-of-day quote
Shenzhen S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 84.68 CNY | -2.76% |
|
-2.17% | -5.01% |
| 09-17 | Fujian Cosunter Receives Shareholder Proposal from Fujian Effort Group | CI |
| 09-07 | Cosunter Pharma Enrolls First Patient in Phase II Trial of Anti-Hepatitis B Drugs | MT |
| Market Cap | 14.23B 2.12B 1.86B 1.76B 1.6B 3B 203B 3.02B 21.02B 8.14B 104B 7.96B 7.79B 334B | P/E 2024 |
-33.3x | P/E 2025 | -65.2x |
|---|---|---|---|---|---|
| Enterprise Value | 14.47B 2.16B 1.89B 1.79B 1.63B 3.05B 207B 3.07B 21.38B 8.28B 106B 8.09B 7.92B 339B | EV / Sales 2024 |
12.5x | EV / Sales 2025 | 34.7x |
| Free-Float |
54.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.76% | ||
| 1 week | -2.17% | ||
| Current month | -7.26% | ||
| 1 month | -8.21% | ||
| 3 months | -7.67% | ||
| 6 months | -14.53% | ||
| Current year | -5.01% |
| 1 week | 84.68 |  | 89.66 |
| 1 month | 83.85 | | 95.66 |
| Current year | 79 | | 149 |
| 1 year | 79 | | 149 |
| 3 years | 14.16 | | 188.93 |
| 5 years | 14.16 | | 188.93 |
| 10 years | 14.16 | | 188.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 58 | 2020-03-24 |
Jian Hui Guan
DFI | Director of Finance/CFO | 50 | 2017-07-24 |
Fu hu Huang
COO | Chief Operating Officer | 50 | 2025-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Guo Ping Li
CHM | Chairman | 58 | 2001-06-27 |
Li Qing Ye
BRD | Director/Board Member | 56 | 2011-09-19 |
Guo Dong Li
BRD | Director/Board Member | 55 | 2001-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/6/23 | Sell | Chief Executive Officer | 441,900 | 0.3316% | ||
| 6/5/23 | Sell | Chief Executive Officer | 376,100 | 0.2822% | ||
| 5/22/23 | Sell | Chief Executive Officer | 238,800 | 0.1792% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.76% | -2.17% | -30.34% | +219.07% | 2.12B | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.05% | +0.45% | +24.59% | +65.63% | 364.05B | |
| Weighted average by Cap. | +0.02% | +1.31% | +41.49% | +67.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 441M 65.76M 57.71M 54.5M 49.67M 92.98M 6.3B 93.64M 652M 253M 3.22B 247M 242M 10.35B | 416M 62.03M 54.43M 51.41M 46.85M 87.69M 5.94B 88.32M 615M 238M 3.04B 233M 228M 9.76B |
| Net income | -156M -23.28M -20.43M -19.3M -17.59M -32.92M -2.23B -33.15M -231M -89.44M -1.14B -87.42M -85.53M -3.66B | -218M -32.45M -28.48M -26.9M -24.51M -45.88M -3.11B -46.21M -322M -125M -1.59B -122M -119M -5.11B |
| Net Debt | 299M 44.48M 39.03M 36.87M 33.6M 62.89M 4.26B 63.34M 441M 171M 2.18B 167M 163M 7B | 242M 36.06M 31.64M 29.88M 27.23M 50.98M 3.46B 51.34M 358M 138M 1.77B 135M 132M 5.67B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | CN¥84.68 | -2.76% | 2,126,884 |
| 26-09-23 | CN¥87.08 | -0.77% | 2,193,807 |
| 26-09-22 | CN¥87.76 | -1.28% | 3,163,701 |
| 26-09-21 | CN¥88.90 | +2.70% | 3,721,901 |
| 26-09-18 | CN¥86.56 | +1.80% | 2,795,818 |
- Stock Market
- Stocks
- 300436 Stock
Select your edition
All financial news and data tailored to specific country editions
